Extramammary Paget's disease medical therapy: Difference between revisions
Simrat Sarai (talk | contribs) No edit summary |
Simrat Sarai (talk | contribs) No edit summary |
||
| Line 36: | Line 36: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
: | :Paclitaxel | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Paclitaxel's mechanism of action involves interference with the normal breakdown of microtubules during cell division | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | |||
:Trastuzumab | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Trastuzumab is a recombinant monoclonal antibody against human epidermal growth factor receptor 2 (HER2). It is effective when tumor cells overexpress HER2 protein. | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
Revision as of 23:18, 5 February 2016
|
Extramammary Paget's disease Microchapters |
|
Differentiating Extramammary Paget's disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Extramammary Paget's disease medical therapy On the Web |
|
American Roentgen Ray Society Images of Extramammary Paget's disease medical therapy |
|
Directions to Hospitals Treating Extramammary Paget's disease |
|
Risk calculators and risk factors for Extramammary Paget's disease medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Chemotherapy therapy with either 5-fluorouracil, imiquimod cream, or the combination of paclitaxel and trastuzumab may be helpful in the treatment of extramammary Paget's disease.[1][2][3][4]
Medical Therapy
The following medical therapies have been studied for the treatment of extramammary Paget's disease:[1][2][3][4]
- 5-fluorouracil
- Imiquimod
- Combination of paclitaxel and trastuzumab
| Medication | Mechanism of action | Dosage |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
References
- ↑ 1.0 1.1 Takahagi S, Noda H, Kamegashira A, Madokoro N, Hori I, Shindo H; et al. (2009). "Metastatic extramammary Paget's disease treated with paclitaxel and trastuzumab combination chemotherapy". J Dermatol. 36 (8): 457–61. doi:10.1111/j.1346-8138.2009.00676.x. PMID 19691751.
- ↑ 2.0 2.1 Sendagorta E, Herranz P, Feito M, Ramírez P, Floristán U, Feltes R; et al. (2010). "Successful treatment of three cases of primary extramammary Paget's disease of the vulva with Imiquimod--proposal of a therapeutic schedule". J Eur Acad Dermatol Venereol. 24 (4): 490–2. doi:10.1111/j.1468-3083.2009.03451.x. PMID 19840203.
- ↑ 3.0 3.1 Marchitelli C, Peremateu MS, Sluga MC, Berasategui MT, Lopez DG, Wernicke A; et al. (2014). "Treatment of primary vulvar paget disease with 5% imiquimod cream". J Low Genit Tract Dis. 18 (4): 347–50. doi:10.1097/LGT.0000000000000053. PMID 25259595.
- ↑ 4.0 4.1 Beleznay KM, Levesque MA, Gill S (2009). "Response to 5-fluorouracil in metastatic extramammary Paget disease of the scrotum presenting as pancytopenia and back pain". Curr Oncol. 16 (5): 81–3. PMC 2768510. PMID 19862365.